SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (126)	9/1/2000 8:16:26 AM
From: blue_chip	of 164

News Release Oncolytics Biotech Inc. Receives U.S. Patent Approval Oncolytics Biotech Inc ONC Shares issued 16,919,080 Aug 31 close $12.40 Fri 1 Sept 2000 News Release Mr. Matt Coffey reports The U.S. Patent and Trademark Office has issued patent 6,110,461 to Oncolytics effective Aug. 29, 2000. The patent covers the pharmaceutical use of the reovirus in the treatment of Ras-mediated cancers in mammals. "The issuance of this patent provides us with our initial proprietary position with respect to the development of reovirus as a therapeutic for the treatment of cancer," said Dr. Matt Coffey, vice-president, product development. "It is exciting and gratifying to receive approval for these broad-based claims. It solidifies our platform by providing intellectual property protection and removes an important element of risk in the development and commercialization process." WARNING: The company relies on litigation protection for "forward-looking" statements. *Onc is 35% owned by Syb More info at thenextwave.emerchantpro.com regards chip

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next